APOA2 and pancreatic intraductal papillary-mucinous neoplasm: The positive rates of apoA2-ATQ/AT for IPMN and chronic pancreatitis were 16.7% (95% CI 7.3–33.6%) and 40% (95% CI 16.8–68.7%), respectively (Supplemental Table 2).